The IHC And ISH Slide Staining System Market are Projected To Reach USD 7.2 Billion By 2030, From USD 4.3 Billion in 2022,Registering a CAGR Of 6.80% During The Forecast Period 2023-2030| Data By Contrive Datum Insights Pvt Ltd.
April 28, 2023 12:02 ET
|
Contrive Datum Insights Pvt Ltd
Farmington, April 28, 2023 (GLOBE NEWSWIRE) -- The Global IHC and ISH slide staining system Market size was valued at USD 4.3 Billion in 2022 and is projected to reach USD 7.2 Billion by 2030,...
AnPac Bio Reports 49.1% Decrease in Net Loss in First Quarter of Fiscal 2022
May 31, 2022 17:00 ET
|
AnPac Bio-Medical Science Co., Ltd.
PHILADELPHIA, May 31, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
AnPac Bio’s Bio-Chip Subsidiary, Changwei System Technology Co., Ltd., Receives Independent Valuation and Approval from the Board to Explore Strategic Alternatives
March 03, 2022 07:00 ET
|
AnPac Bio-Medical Science Co., Ltd.
PHILADELPHIA, March 03, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in the United States and...
AnPac Bio Files CDA Device for Breakthrough Medical Device Designation Request with the FDA
February 03, 2022 07:30 ET
|
AnPac Bio-Medical Science Co., Ltd.
PHILADELPHIA, Feb. 03, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in the United States and...
AnPac Bio Class III Medical Device Passes Extensive NMPA Registration Tests and Will Start Clinical Trial in Q1, 2022
January 04, 2022 07:30 ET
|
AnPac Bio-Medical Science Co., Ltd.
PHILADELPHIA, Jan. 04, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a US and China-based biotechnology company focused on early cancer...
Technical Paper on AnPac Bio Novel CDA Cancer Detection Technology Published by Peer-Reviewed International Medical Journal
December 10, 2021 07:30 ET
|
AnPac Bio-Medical Science Co., Ltd.
PHILADELPHIA, Dec. 10, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Wheelhouse at Center of Nascent Industry
October 13, 2021 08:30 ET
|
Avricore Health Inc.
NEW YORK, Oct. 13, 2021 (GLOBE NEWSWIRE) -- via InvestorWire — Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"),...
AnPac Bio Study Shows Strong Correlation between CDA Score and Risk of Cancer and Diseases
October 04, 2021 07:30 ET
|
Anpac Bio, USA
PHILADELPHIA, Oct. 04, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (Nasdaq:ANPC, “AnPac Bio,” the “Company” or “we”), a biotechnology company with operations in China and the United...
AnPac Bio Increases Ownership Percentage of its Subsidiary AnPai Healthcare from 20% to 60%
September 03, 2021 16:15 ET
|
Anpac Bio, USA
PHILADELPHIA, Sept. 03, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in the United States...
AnPac Bio’s USA Laboratory Receives Accreditation from the College of American Pathologists
August 30, 2021 07:30 ET
|
Anpac Bio, USA
PHILADELPHIA, Aug. 30, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in the United States...